Cargando…
Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
BACKGROUND: Diabetes is a serious public health concern in China, with 30% of patients developing retinopathy, and diabetic macular edema (DME) having the biggest impact on vision. High blood glucose level can cause retinal cell hypoxia, thus promoting vascular endothelial growth factor (VEGF) forma...
Autores principales: | Li, Yun-Fei, Ren, Qian, Sun, Chao-Hui, Li, Li, Lian, Hai-Dong, Sun, Rui-Xue, Su, Xian, Yu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329842/ https://www.ncbi.nlm.nih.gov/pubmed/36051431 http://dx.doi.org/10.4239/wjd.v13.i7.532 |
Ejemplares similares
-
Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
por: Maitra, Puja, et al.
Publicado: (2023) -
Conbercept combined with laser photocoagulation in the treatment of diabetic macular edema and its influence on intraocular cytokines
por: Zhan, Hui-Qin, et al.
Publicado: (2023) -
Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
por: Kong, Xiang-Quan, et al.
Publicado: (2018) -
Serum vascular endothelial growth factor and cortisol expression to predict prognosis of patients with hypertensive cerebral hemorrhage
por: Zhang, Chao-Yong, et al.
Publicado: (2023) -
Anti-vascular endothelial growth factor treatment in diabetic macular edema
por: Kim, Moosang
Publicado: (2016)